How We Treat Fever and Hypotension in Pediatric Hematopoietic Cell Transplant Patients.
- Author(s): Zinter, Matt S
- Dvorak, Christopher C
- Auletta, Jeffery J
- et al.
Published Web Locationhttps://doi.org/10.3389/fonc.2020.581447
Pediatric allogeneic hematopoietic cell transplant (HCT) survival is limited by the development of post-transplant infections. In this overview, we discuss a clinical approach to the prompt recognition and treatment of fever and hypotension in pediatric HCT patients. Special attention is paid to individualized hemodynamic resuscitation, thorough diagnostic testing, novel anti-pathogen therapies, and the multimodal support required for recovery. We present three case vignettes that illustrate the complexities of post-HCT sepsis and highlight best practices that contribute to optimal transplant survival in children.